AAAAAA
Results: 26-38/38
Authors:
Daelemans, D
Schols, D
Witvrouw, M
Pannecouque, C
Hatse, S
van Dooren, S
Hamy, F
Klimkait, T
De Clercq, E
Vandamme, AM
Citation: D. Daelemans et al., A second target for the peptoid Tat/transactivation response element inhibitor CGP64222: Inhibition of human immunodeficiency virus replication by blocking CXC-chemokine receptor 4-mediated virus entry, MOLEC PHARM, 57(1), 2000, pp. 116-124
Authors:
Witvrouw, M
Weigold, H
Pannecouque, C
Schols, D
De Clercq, E
Holan, G
Citation: M. Witvrouw et al., Potent Anti-HTV (type 1 and type 2) activity of polyoxometalates: Structure-activity relationship and mechanism of action, J MED CHEM, 43(5), 2000, pp. 778-783
Authors:
Vandamme, AM
Witvrouw, M
Pannecouque, C
Balzarini, J
Van Laethem, K
Schmit, JC
Desmyter, J
De Clercq, E
Citation: Am. Vandamme et al., Evaluating clinical isolates for their phenotypic and genotypic resistanceagainst anti-HIV drugs, METH MOL M, 24, 2000, pp. 223-258
Authors:
Arranz, ME
Diaz, JA
Ingate, ST
Witvrouw, M
Pannecouque, C
Balzarini, J
De Clercq, E
Vega, S
Citation: Me. Arranz et al., Synthesis and anti-HIV activity of 1,1,3-trioxo-2H,4H-thieno[3,4-e][1,2,4]thiadiazines (TTDs): A new family of HIV-1 specific non-nucleoside reverse transcriptase inhibitors, BIO MED CH, 7(12), 1999, pp. 2811-2822
Authors:
Chimirri, A
Grasso, S
Monforte, P
Rao, A
Zappala, M
Monforte, AM
Pannecouque, C
Witvrouw, M
Balzarini, J
De Clercq, E
Citation: A. Chimirri et al., Synthesis and biological activity of novel 1H,3H-thiazolo[3,4-a] benzimidazoles: non-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors, ANTIVIR CHE, 10(4), 1999, pp. 211-217
Authors:
Van Gelder, J
Witvrouw, M
Pannecouque, C
Henson, G
Bridger, G
Naesens, L
De Clercq, E
Annaert, P
Shafiee, M
Van den Mooter, G
Kinget, R
Augustijns, P
Citation: J. Van Gelder et al., Evaluation of the potential of ion pair formation to improve the oral absorption of two potent antiviral compounds, AMD3100 and PMPA, INT J PHARM, 186(2), 1999, pp. 127-136
Authors:
Witvrouw, M
Pannecouque, C
De Clercq, E
Fernandez-Alvarez, E
Marco, JL
Citation: M. Witvrouw et al., Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives, ARCH PHARM, 332(5), 1999, pp. 163-166
Authors:
Witvrouw, M
Pannecouque, C
Van Laethem, K
Desmyter, J
De Clercq, E
Vandamme, AM
Citation: M. Witvrouw et al., Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV, AIDS, 13(12), 1999, pp. 1477-1483
Authors:
Ruell, JA
De Clercq, E
Pannecouque, C
Witvrouw, M
Stup, TL
Turpin, JA
Buckheit, RW
Cushman, M
Citation: Ja. Ruell et al., Synthesis and anti-HIV activity of cosalane analogues with substituted benzoic acid rings attached to the pharmacophore through methylene and amide linkers, J ORG CHEM, 64(16), 1999, pp. 5858-5866
Authors:
Lin, ZW
Neamati, N
Zhao, H
Kiryu, Y
Turpin, JA
Aberham, C
Strebel, K
Kohn, K
Witvrouw, M
Pannecouque, C
Debyser, Z
De Clercq, E
Rice, WG
Pommier, Y
Burke, TR
Citation: Zw. Lin et al., Chicoric acid analogues as HIV-1 integrase inhibitors, J MED CHEM, 42(8), 1999, pp. 1401-1414
Authors:
Cushman, M
Insaf, S
Paul, G
Ruell, JA
De Clercq, E
Schols, D
Pannecouque, C
Witvrouw, M
Schaeffer, CA
Turpin, JA
Williamson, K
Rice, WG
Citation: M. Cushman et al., Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency, J MED CHEM, 42(10), 1999, pp. 1767-1777
Authors:
Pandeya, SN
Yogeeswari, P
Sriram, D
de Clercq, E
Pannecouque, C
Witvrouw, M
Citation: Sn. Pandeya et al., Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives, CHEMOTHERA, 45(3), 1999, pp. 192-196
Authors:
Leydet, A
Moullet, C
Roque, JP
Witvrouw, M
Pannecouque, C
Andrei, G
Snoeck, R
Neyts, J
Schols, D
De Clercq, E
Citation: A. Leydet et al., Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission, J MED CHEM, 41(25), 1998, pp. 4927-4932